Schlaefer Optometrists | |
128 W Main St. Campbellsport WI 53010 | |
(920) 533-8426 | |
(920) 533-8380 |
Full Name | Schlaefer Optometrists |
---|---|
Speciality | Clinic/center |
Location | 128 W Main St., Campbellsport, Wisconsin |
Authorized Official Name and Position | Ann Therese Schlaefer (OWNER) |
Authorized Official Contact | 9205338426 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Schlaefer Optometrists 128 W Main St. P.o. Box 209 Campbellsport WI 53010 Ph: (920) 533-8426 | Schlaefer Optometrists 128 W Main St. Campbellsport WI 53010 Ph: (920) 533-8426 |
NPI Number | 1154557817 |
---|---|
Provider Enumeration Date | 06/08/2009 |
Last Update Date | 06/08/2009 |
Identifier | Type | State | Issuer |
---|---|---|---|
1154557817 | NPI | - | NPPES |
38586400 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261Q00000X | Clinic/center | (* (Not Available)) | Primary |
News Archive
High-intensity exercise three times a week is safe for individuals with early-stage Parkinson's disease and decreases worsening of motor symptoms, according to a new phase 2, multi-site trial led by University of Colorado Anschutz Medical Campus and Northwestern Medicine scientists.
Increasing sleep duration may help reduce cardiometabolic risk-or the risk of heart disease and metabolic disorders- in individuals who do not get enough sleep, according to an analysis of all published studies on the topic.
Since 2000, nearly 1,000 "retail clinics" - offering routine care like sports physicals and immunizations and treatment for minor illnesses like strep throat - have opened their doors inside pharmacies and grocery stores across the United States. Retail chain operators proposed that the new clinics would improve access to medical care among uninsured or underserved populations.
GlobalPost's "Global Pulse" blog examines questions surrounding the use of the antiretroviral Truvada for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection among people at high risk, as studies released and panel discussions held last week at the XIX International AIDS Conference (AIDS 2012) "raised concerns about the drug's effect on the future of the AIDS fight."
› Verified 9 days ago